What does it mean to do the heavy lifting?

In clinical research, it means assisting with research and development of new drugs alongside pharmaceutical and biotechnology companies, helping them complete the routine work that turns the gears to make new medicines. 

Within pharma, contract research organizations (CROs) are indispensable partners in the advancement of clinical research who manage the complexities of clinical trials from protocol design to regulatory closeout, handling tasks like trial design, patient recruitment, data management, and regulatory submissions.

As a result, CROs have become indispensable partners in the advancement of clinical research who significantly contribute to our industry’s development of groundbreaking treatments, and human health.

However, the weights and the lifting methods have been changing. As Boston Consulting Group noted in their 2024 Nature article, clinical trials are becoming more complex. As a result, CROs face increasing pressure to deliver more with less.

Recognizing their importance in our mission and vision, Medable is excited to announce the launch of our comprehensive CRO partner program, designed to be a game-changing engine for growth and control in the clinical research industry.  

Tools that enable business wins

The foundation of our program rests on the simple premise that partnering with Medable should be as simple and transparent as possible, with access to all of the same tools, people, and processes that Medable uses to assist our customers' trials. 

Thus, CROs are armed with the latest Medable technology, including generative AI, that enables them to build high-quality studies in seconds. The impact of this has been immense, as study teams using this technology are able to gain a competitive advantage by walking into meetings with a pre-built digital study, ready for instant feedback and real-time updates. 

In addition, Medable is pairing our tools with a brand new CRO pricing calculator, which provides study-specific quotes in just 30 seconds, ensuring clear, upfront pricing without hidden costs. 

The impact of these is that CROs are able to build studies in much more efficient and smarter ways than before, respond to changes better, better simulate trials, and win more often.

Different levels of service for different types of CROs

Recognizing that CROs have diverse operational needs, Medable offers flexible service models. Our managed service option provides end-to-end study builds handled entirely by Medable, including dedicated expertise for instrument and translation management, device provisioning, and comprehensive training and support. 

For those seeking a more collaborative approach, the hybrid service includes unlimited workspace for sponsor demonstrations, shared study support, and a cooperative training model to help partners build their own capabilities. 

Finally, the self service option fully enables partners to manage builds independently, with flexible add-on support for specific needs, full training, help desk assistance, and priority input on future platform developments and early access to new AI features.

Delivering long-term CRO growth

Our goal is to help CROs achieve long-term growth through technology and partnerships that drive competitive advantages and trusted relationships with their customers.

In an industry where differentiation is increasingly difficult to achieve, the Medable partner program provides CROs with a distinct competitive edge that directly addresses sponsors' most pressing concerns, all while simultaneously improving the study experience for sites, sponsors, and patients.

By leveraging Medable Studio's AI-powered capabilities, study teams can dramatically accelerate build times through intuitive visual eCOA building tools, while maintaining access to an extensive portfolio content library that eliminates redundant work. Tools like the Translation Workbench and point-and-click Schedule of Activities builder further streamline what were once time-consuming manual processes. This not only removes weeks of time from the trial build, it allows study teams to focus on higher-value activities. 

Beyond the technology itself, the program's partner incentives create a sustainable financial model where CROs save money while scaling operations effortlessly, all while guaranteeing complete pricing transparency through a self-service calculator that eliminates the frustration of hidden fees and unexpected costs. 

However, the true value lies within the customer confidence that comes as a result of continually exceeding key milestones well ahead of schedule. This includes things on the critical path such as eCOA builds, first-patient-in (FPI), translation build times, regulatory approval, and more. These operational improvements, combined with measurably higher site and patient adherence rates, create a compelling narrative that resonates strongly with sponsors seeking reliable partners. 

A better, more collaborative approach

Medable envisions a future where CROs, empowered by Medable's technology and support, not only navigate the increasing complexities of clinical trials with greater ease and efficiency but also emerge as even more strategic and indispensable partners to sponsors. 

Together, we can accelerate the delivery of life-changing therapies to patients, ushering in a new era of streamlined, transparent, and ultimately more impactful clinical research. 

We invite you to join us in building this future, one partnership at a time. Learn more, here.

‍